SCHEMBL6370946

SCHEMBL6370946

Cn1cc(-c2ccncc2)c(-c2ccc(F)cc2)c1C(=O)NCC(=O)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 12/20 0.43
MAPK10 P53779 1/20 0.43
ALDH1A1 P00352 3/20 0.42
MAPT P10636 2/20 0.42
LMNA P02545 1/20 0.42
GSK3B P49841 3/20 0.42
SLC6A9 P48067 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.39
PLOD2 O00469 1/20 0.39
PLOD3 O60568 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
HPGD P15428 1/20 0.39
CYP2C19 P33261 1/20 0.39
PLOD1 Q02809 1/20 0.39
HIF1A Q16665 1/20 0.39
ROCK2 O75116 1/20 0.38
MAPK13 O15264 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6219664 0.79 MAPK14 (0.49) MAPK14MAPK13CSNK1DCSNK1EMAPK12
SCHEMBL27627780 0.78 MAPK14 (0.46) MAPK14MAPK13CSNK1DCSNK1EMAPK12
SCHEMBL6220500 0.76 MAPK14 (0.50) MAPK14CYP2C9CYP2C19MAPK13CSNK1D
SCHEMBL6375585 0.76 HTR3A (0.55) MAPK14MAPK13CSNK1DCSNK1EMAPK12
SCHEMBL25222456 0.75 IKBKB (0.49) MAPK14MAPK13CSNK1DCSNK1EMAPK12
SCHEMBL6371945 0.70 MAPK14 (0.42) MAPK14MAPK13CSNK1DCSNK1EMAPK12
SCHEMBL6176453 0.69 MAPK14 (0.52) MAPK14MAPK10ALDH1A1MAPTLMNA
SCHEMBL10988622 0.69 ALDH1A1 (0.68) ALDH1A1GSK3BSLC6A9L3MBTL1PLOD2
SCHEMBL28484131 0.69 ALDH1A1 (0.73) ALDH1A1MAPTLMNASLC6A9CYP1A2
SCHEMBL23014282 0.69 ALDH1A1 (0.73) ALDH1A1MAPTLMNASLC6A9CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050043331-A1 Substituted 3-(2,5-disubstituted)pyridyl-4-aryl pyrroles for treating inflammatory diseases JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050043331-A1 Substituted 3-(2,5-disubstituted)pyridyl-4-aryl pyrroles for treating inflammatory diseases TNF, TSLP, IRAK1 MAPK14 240/4885MAPK10 55/4885ALDH1A1 1528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.